acute%20pericarditis
ACUTE PERICARDITIS

Pericarditis is the inflammation of the pericardial sac and accounts for 5% of visits to the emergency room for chest pain without myocardial infarction.

The patient experiences chest pain that is sharp, pleuritic and improves with sitting up and leaning forward.

Acute pericarditis is characterized by new-onset pericarditis with at least 2 of the following:

  • Pericarditic chest pain
  • Pericardial friction rubs
  • New or worsening pericardial effusion
  • ECG finding of a new diffuse ST-segment elevation or PR depression
  1. Adler Y, Charron P, Imazio M, et al; European Society of Cardiology (ESC). 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015 Nov 7;36(42):2921-2964. doi: 10.1093/eurheartj/ehv318. PMID: 26320112
  2. Daskalov IR, Valova-Ilieva T. Management of acute pericarditis: treatment and follow-up. European Society of Cardiology (ESC). https://www.escardio.org/. 13 Sep 2017.
  3. Imazio M. Acute pericarditis: treatment and prognosis. UpToDate. https://www.uptodate.com/. 18 Sep 2017.
  4. Lilly LS. Treatment of acute and recurrent idiopathic pericarditis. Circulation. 2013 Apr 23;127(16):1723-1726. doi: 10.1161/CIRCULATIONAHA.111.066365. PMID: 23609551
  5. Rahman A, Saraswat A. Pericarditis. Aust Fam Physician. 2017 Nov;46(11):810-814. https://www.racgp.org.au/. PMID: 29101915
  6. Xanthopoulos A, Skoularigis J. Diagnosis of acute pericarditis. European Society of Cardiology (ESC). https://www.escardio.org/. 06 Sep 2017.
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
3 days ago
New drug applications approved by US FDA as of 01 - 15 July 2019 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.